BIOTU (Biotech Acquisition Co) Other Long-Term Liabilities : $1.05 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Biotech Acquisition Co Other Long-Term Liabilities?

Biotech Acquisition Co's other long-term liabilities for the quarter that ended in Sep. 2022 was $1.05 Mil.

Biotech Acquisition Co's quarterly other long-term liabilities declined from Mar. 2022 ($11.95 Mil) to Jun. 2022 ($1.54 Mil) and declined from Jun. 2022 ($1.54 Mil) to Sep. 2022 ($1.05 Mil).

Biotech Acquisition Co's annual other long-term liabilities stayed the same from . 20 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($18.51 Mil).

Biotech Acquisition Co Other Long-Term Liabilities Historical Data

The historical data trend for Biotech Acquisition Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Acquisition Co Other Long-Term Liabilities Chart

Biotech Acquisition Co Annual Data

Trend

Dec20

Dec21

Other Long-Term Liabilities

18.51

Biotech Acquisition Co Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Long-Term Liabilities	Get a 7-Day Free Trial				11.54	18.51	11.95	1.54	1.05

Biotech Acquisition Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biotech Acquisition Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biotech Acquisition Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Acquisition Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Biotech Acquisition Co (NAS:BIOTU) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 West 25th Street, 20th Floor, New York, NY, USA, 10001

Website

Biotech Acquisition Co is a blank check company.

Executives

Albert F Hummel	director, officer: Chief Investment Officer	PO BOX 3407, RANCHO SANTA FE CA 92067
Biotech Sponsor Llc	10 percent owner	545 W. 25TH ST., 20TH FLOOR, NEW YORK NY 10001
Bruno Montanari	director	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Ivan Jarry	officer: Chief Operating Officer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001
Paul Bernard	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Aaron Kim	director	545 WEST 25TH STREET 20TH FL, NEW YORK NY 10001
Michael Schleifer	director, 10 percent owner, officer: Chief Executive Officer	545 WEST 25TH STREET 20TH FLOOR, NEW YORK NY 10001
Thomas Fratacci	officer: CFO & Treasurer	545 WEST 25TH STREET, 20TH FLOOR, NEW YORK NY 10001